...

Quote

anonymous

Guest
So many questions feel free to comment!
1) How are we possibly supposed to have a POA meeting in October?? Seriously, THIS IS RISKY.
2) As of today, Matt W. is no longer an RSD...why?
3) What is Kowa's angle here bringing in 2 generic drugs into 1?? Will that sell/will all of us be punished for sucking a** and cant sell this thing?
 



anonymous said:
So many questions feel free to comment!
1) How are we possibly supposed to have a POA meeting in October?? Seriously, THIS IS RISKY.
2) As of today, Matt W. is no longer an RSD...why?
3) What is Kowa's angle here bringing in 2 generic drugs into 1?? Will that sell/will all of us be punished for sucking a** and cant sell this thing?
Click to expand...
 






Yes, it will be a difficult sell. Yes, we will be liable if sales don’t go well. I once sold a combination generic with an OTC…it was a tough sell. This will be too. It is what it is…
 



Seems to be a very uphill battle , two generics and one that is tough to write . Hoping for the best but think we are all scared . Def thought we would be getting another drug in similar space .
 



My manager rode with me today and she said that Kowa is not going to demand vaccinations…yet. When the Moderna vaccine gets full FDA approval, that likely will change.
 












Top Bottom
Back
Quote